Mrinalini Dey DrMiniDey
5 years 11 months ago
Time-trend analysis in hospitalised #infection in #lupus
-Incr. rate of hospitalised infections over time
-#Sepsis surpassed #pneumonia as most common hospitalised infection in 2011-12; twice as many sepsis vs pneumonia by 2015-16
Abs#0980 #ACR20 @RheumNow
https://t.co/M8xbMDFUTS https://t.co/ShogvxbhzN
Richard Conway RichardPAConway
5 years 11 months ago
Dr Cai presents risk of CVD in gout in study 450,000 patients. Gout was independently associated with an increased risk of CVD events HR = 1.24 for women; 1.21 for men. @rheumnow #ACR20 Abstr#950 #ACRbest https://t.co/089aKtN5a7
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
Click here to listen.
Treat to Target in Spondyloarthritis: Dr. Rachel Tate
Dr. Tate discusses abstracts #0879, #0893 and #1892 presented at the ACR20 annual meeting.
Another great way to get highlights from the ACR 2020 meeting - listen in to faculty reports and overviews.
Click here to listen
Robert B Chao, MD doctorRBC
5 years 11 months ago
Racial disparity in SSc-ILD pts treated with MMF?
1️⃣Early initiation of MMF significantly slowed ⬇️ of FVC%
2️⃣No difference in MMF efficacy between African-Americans and non-AA
3️⃣AA had baseline lower FVC%
@RheumNow #ACR20 Abs0929 https://t.co/rtsbe7OCvA
Olga Petryna DrPetryna
5 years 11 months ago
@RheumNow #acr20 abs0876 gender differences AS and nrSpA from 3 RCT IXE trials: F more likely to be older, have more nocturnal BP, peripheral pain&fatigue. M have higher CRP & +HLAB27. Ant uveitis > in M w/AS (23.8% vs. 17.9%) but > common in F w/ nr-axSpA (15.2% vs. 7.1%). https://t.co/HZa7AfWbBh
Dr. John Cush RheumNow
5 years 11 months ago
The RheumNow podcast on #ACR20 Day 1 Part II is now available for download. Follow the link below to listen in or find us on Apple.
https://t.co/W6EMQiF9Rf https://t.co/ZlFDiVgAKl
k dao KDAO2011
5 years 11 months ago
Dr Fauci assured the medical community the NIH #COVID19 reccs can be trusted and is a living document that we should access to care for patients with CV19 #ACR20 @RheumNow https://t.co/GrJUvdFFhk
sheila RHEUMarampa
5 years 11 months ago
Such an honor to have @DrFaucis1 at #ACR20! 👏👏👏 He reminds us of the fundamentals to prevent acquiring and transmitting #SARSCoV2 @RheumNow https://t.co/Xu4F8q64RJ
At #ACR20 three different medications are reviewed in different studies to decrease the immunogenicity of pegloticase – Methotrexate, Azathioprine and Mycophenolate Mofetil.
Meral K. El Ramahi, MD MeralElRamahiMD
5 years 11 months ago
Dr. Anthony Fauci’s session has been of the most popular lectures at #ACR20! Checkout highlights from his talk below!
@RheumNow https://t.co/720LUTIncJ
Sole RetamozoSole
5 years 11 months ago
Severe manifestations in #COVID19 infection. Dr Fauci #ACR20 @RheumNow Cytokine storm ⚡️⚡️⛈🌩 https://t.co/qsFjjP5iKG
Dr. Rachel Tate uptoTate
5 years 11 months ago
“We remain cautiously optimistic that we will have a safe, effective vaccine based on animal studies.” Here is an up-to-date list of COVID-19 trials as discussed at #ACR20 by Dr. A. Fauci @RheumNow https://t.co/DAoLGGtw1A
Dr. John Cush RheumNow
5 years 11 months ago
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow + its Faculty.
